A continuous score for knee replacement risk from radiographs: promise, limitations, and the path beyond
The Lancet Medical Imaging & Theranostics · 2026-11 · 100052
DOI: 10.1016/j.lanmit.2026.100052 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Lancet Medical Imaging & Theranostics, 2026-11. Verfasst von Anoosha Pai S und 3 weiteren Autor:innen. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Institute of Biomedical Imaging and Bioengineering.
Abstract (Originalsprache)
Introduced in 1957, the Kellgren–Lawrence grade (KLG) classifies radiographic knee osteoarthritis severity into a subjective, ordinal score (0–4) based on joint space narrowing, subchondral bone changes, and osteophytes. KLG drives extensive osteoarthritis research and selection for knee replacement. However, it was devised for disease classification rather than prognosis. This system discards much of the structural information in the radiograph and shows low-to-moderate reliability, especially at intermediate grades where prognostic uncertainty matters most.
Förderung
- National Institute of Biomedical Imaging and Bioengineering
Zitieren
APA
S, A. P., White, M. S., Chaudhari, A. S., & Gatti, A. A. (2026). A continuous score for knee replacement risk from radiographs: promise, limitations, and the path beyond. The Lancet Medical Imaging & Theranostics, 100052. https://doi.org/10.1016/j.lanmit.2026.100052
Vancouver
S AP, White MS, Chaudhari AS, Gatti AA. A continuous score for knee replacement risk from radiographs: promise, limitations, and the path beyond. The Lancet Medical Imaging & Theranostics. 2026:100052. doi:10.1016/j.lanmit.2026.100052
BibTeX
@article{S2026,
author = {S, Anoosha Pai and White, McKenzie S and Chaudhari, Akshay S and Gatti, Anthony A},
title = {A continuous score for knee replacement risk from radiographs: promise, limitations, and the path beyond},
journal = {The Lancet Medical Imaging & Theranostics},
year = {2026},
pages = {100052},
doi = {10.1016/j.lanmit.2026.100052}
}
EUVIMED